The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 15, 2020

Filed:

Oct. 23, 2017
Applicant:

Modernatx, Inc., Cambridge, MA (US);

Inventors:

Stephane Bancel, Cambridge, MA (US);

Tirtha Chakraborty, Medford, MA (US);

Antonin De Fougerolles, Waterloo, BE;

Sayda M. Elbashir, Cambridge, MA (US);

Matthias John, Cambridge, MA (US);

Atanu Roy, Stoneham, MA (US);

Susan Whoriskey, Belmont, MA (US);

Kristy M. Wood, Wellesley, MA (US);

Paul Hatala, Charlestown, MA (US);

Jason P. Schrum, Philadelphia, PA (US);

Kenechi Ejebe, New York, NY (US);

Jeff Lynn Ellsworth, Lexington, MA (US);

Justin Guild, Framingham, MA (US);

Assignee:

ModernaTX, Inc., Cambridge, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/535 (2006.01); A61K 38/17 (2006.01); A61K 48/00 (2006.01); C12N 15/85 (2006.01); C07K 14/47 (2006.01); C07K 14/62 (2006.01); A61K 31/7115 (2006.01); C12N 9/88 (2006.01); A61K 9/127 (2006.01); C12N 15/11 (2006.01); C07K 14/705 (2006.01); C07K 14/505 (2006.01); C12N 9/64 (2006.01); C12N 9/10 (2006.01); C12N 9/00 (2006.01); C12N 9/42 (2006.01); C12N 15/87 (2006.01); C12P 13/04 (2006.01); A61K 38/45 (2006.01); C07K 14/005 (2006.01); C12N 9/16 (2006.01); C12N 9/24 (2006.01); C12N 15/52 (2006.01); C07K 14/435 (2006.01); C12P 21/00 (2006.01); C07K 14/485 (2006.01); C07H 21/02 (2006.01); C07K 14/475 (2006.01); C07K 14/495 (2006.01); C07K 14/525 (2006.01); C07K 14/54 (2006.01); C07K 14/56 (2006.01); C07K 14/61 (2006.01); C07K 14/745 (2006.01); C07K 16/28 (2006.01); C07K 16/40 (2006.01); C12N 9/02 (2006.01); C12N 9/12 (2006.01); C12N 9/68 (2006.01); A61K 47/54 (2017.01); A61K 9/14 (2006.01); A61K 9/51 (2006.01); A61K 38/18 (2006.01); A61K 38/19 (2006.01); A61K 38/21 (2006.01); A61K 38/48 (2006.01); C07K 14/515 (2006.01); C07K 16/00 (2006.01); A61K 31/7088 (2006.01); A61K 47/10 (2017.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A61K 48/0066 (2013.01); A61K 9/1271 (2013.01); A61K 9/145 (2013.01); A61K 9/5123 (2013.01); A61K 9/5146 (2013.01); A61K 9/5153 (2013.01); A61K 31/7115 (2013.01); A61K 38/17 (2013.01); A61K 38/177 (2013.01); A61K 38/1816 (2013.01); A61K 38/1891 (2013.01); A61K 38/191 (2013.01); A61K 38/193 (2013.01); A61K 38/212 (2013.01); A61K 38/45 (2013.01); A61K 38/4846 (2013.01); A61K 47/543 (2017.08); A61K 48/005 (2013.01); A61K 48/0033 (2013.01); A61K 48/0075 (2013.01); C07H 21/02 (2013.01); C07K 14/005 (2013.01); C07K 14/435 (2013.01); C07K 14/43595 (2013.01); C07K 14/47 (2013.01); C07K 14/475 (2013.01); C07K 14/4705 (2013.01); C07K 14/4713 (2013.01); C07K 14/4723 (2013.01); C07K 14/4746 (2013.01); C07K 14/485 (2013.01); C07K 14/495 (2013.01); C07K 14/505 (2013.01); C07K 14/515 (2013.01); C07K 14/525 (2013.01); C07K 14/535 (2013.01); C07K 14/5418 (2013.01); C07K 14/56 (2013.01); C07K 14/61 (2013.01); C07K 14/62 (2013.01); C07K 14/705 (2013.01); C07K 14/745 (2013.01); C07K 16/00 (2013.01); C07K 16/2863 (2013.01); C07K 16/2887 (2013.01); C07K 16/40 (2013.01); C12N 9/0069 (2013.01); C12N 9/0091 (2013.01); C12N 9/1051 (2013.01); C12N 9/1241 (2013.01); C12N 9/16 (2013.01); C12N 9/2402 (2013.01); C12N 9/2445 (2013.01); C12N 9/644 (2013.01); C12N 9/6435 (2013.01); C12N 9/6437 (2013.01); C12N 9/6443 (2013.01); C12N 9/6451 (2013.01); C12N 9/88 (2013.01); C12N 9/93 (2013.01); C12N 15/11 (2013.01); C12N 15/52 (2013.01); C12N 15/85 (2013.01); C12N 15/87 (2013.01); C12P 13/04 (2013.01); C12P 21/00 (2013.01); C12P 21/005 (2013.01); C12Y 603/02019 (2013.01); A61K 38/00 (2013.01); C12Y 113/12007 (2013.01); C12Y 116/03001 (2013.01); C12Y 207/07012 (2013.01); C12Y 304/21007 (2013.01); C12Y 304/21022 (2013.01); C12Y 304/21027 (2013.01); C12Y 403/02001 (2013.01); Y02A 50/401 (2018.01); Y02A 50/411 (2018.01); Y02A 50/414 (2018.01); Y02A 50/415 (2018.01); Y02A 50/423 (2018.01); Y02A 50/463 (2018.01); Y02A 50/491 (2018.01);
Abstract

The invention relates to a pharmaceutical composition including a plurality of lipid nanoparticles having a mean particle size of between 80 nm and 160 nm and containing an mRNA encoding a polypeptide. The lipid nanoparticles include a cationic lipid, a neutral lipid, a cholesterol, and a PEG lipid. The mRNA contains a 5'-cap, 5′-UTR, a 3′-UTR, and a poly-A region with at least 100 nucleotides.


Find Patent Forward Citations

Loading…